PYZCHIVA

NDC 61314-654 · SANDOZ INC

Generic nameustekinumab-ttwe

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)USTEKINUMAB

Strength130 mg/26mL

Pharmacologic classInterleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]

Marketing categoryBLA

Packages

61314-654-94 — 1 VIAL, SINGLE-USE in 1 CARTON (61314-654-94) / 26 mL in 1 VIAL, SINGLE-USE

Billed under HCPCS

Q9997 — Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg Medicare Part B payment limit (ASP + 6%): $8.55

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9171 — ustekinumab-hmny, 50090-7769 — ustekinumab-aekn, 57894-054 — ustekinumab, 57894-060 — ustekinumab, 57894-061 — ustekinumab, 57894-440 — ustekinumab, 57894-441 — ustekinumab, 57894-444 — ustekinumab, 61314-651 — ustekinumab-ttwe, 61314-652 — ustekinumab-ttwe, 65219-822 — ustekinumab-aauz, 65219-824 — ustekinumab-aauz, 65219-826 — ustekinumab-aauz, 65219-828 — ustekinumab-aauz, 65219-862 — ustekinumab-aauz, 65219-866 — ustekinumab-aauz, 72606-027 — ustekinumab-stba, 72606-028 — ustekinumab-stba, 72606-029 — ustekinumab-stba, 72606-060 — ustekinumab-stba, +20 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.